Pharmacokinetics (PK) of ibrutinib in patients with chronic lymphocytic leukemia (CLL). This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback